Gabriel Schäfer

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Organic letters

Journal of medicinal chemistry

Idorsia Pharmaceuticals Ltd.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Idorsia Pharmaceuticals Ltd. Mar 01 2020

Switzerland

Director, Group Leader :: Chemistry Process R&D

Idorsia Pharmaceuticals Ltd. - Feb 29 2020

Switzerland

Scientist :: Chemistry Process R&D

Publications

Lucia Pincekova, Aurélien Merot, Gabriel Schäfer, Michael C Willis
Sandmeyer Chlorosulfonylation of (Hetero)Aromatic Amines Using DABSO as an SO 2 Surrogate. Organic letters 26 (28) (2024)
Lucia Pincekova, Aurélien Merot, Gabriel Schäfer, Michael C Willis
Sandmeyer Chlorosulfonylation of (Hetero)Aromatic Amines Using DABSO as an SO 2 Surrogate. Organic letters 26 (28) (2024)
Emmanuel A Meyer, Andrew L Croxford, Carmela Gnerre, Paulina Kulig, Mark J Murphy, Elise M Jacob, Gabriel Schäfer, Sylvia Richard-Bildstein, Hamed Aissaoui, Patrick Bouis, Eric A Ertel, Ruben de Kanter, Marcel P Keller, Urs Lüthi, Eva Caroff
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of medicinal chemistry 67 (10) (2024)
Lucia Pincekova, Aurélien Merot, Gabriel Schäfer, Michael C Willis
Sandmeyer Chlorosulfonylation of (Hetero)Aromatic Amines Using DABSO as an SO 2 Surrogate. Organic letters 26 (28) (2024)
Lucia Pincekova, Aurélien Merot, Gabriel Schäfer, Michael C Willis
Sandmeyer Chlorosulfonylation of (Hetero)Aromatic Amines Using DABSO as an SO 2 Surrogate. Organic letters (2024)
Emmanuel A Meyer, Andrew L Croxford, Carmela Gnerre, Paulina Kulig, Mark J Murphy, Elise M Jacob, Gabriel Schäfer, Sylvia Richard-Bildstein, Hamed Aissaoui, Patrick Bouis, Eric A Ertel, Ruben de Kanter, Marcel P Keller, Urs Lüthi, Eva Caroff
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of medicinal chemistry (2024)
Sylvia Richard-Bildstein, Hamed Aissaoui, Julien Pothier, Gabriel Schäfer, Carmela Gnerre, Eleanor Lindenberg, François Lehembre, Laetitia Pouzol, Philippe Guerry
Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239. Journal of medicinal chemistry 63 (24) (2020)
Gabriel Schäfer, Muhamed Ahmetovic, Stefan Abele
Scalable Synthesis of Trifluoromethylated Imidazo-Fused N-Heterocycles Using TFAA and Trifluoroacetamide as CF3-Reagents. Organic letters 19 (24) (2017)

Gabriel Schäfer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gabriel Schäfer